Merriman Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Merriman Wealth Management's LLY Position: Q4 2024 in Review
Merriman Wealth Management reduced its Eli Lilly (LLY) stake by 62% in Q4 2024, selling an estimated $500K and leaving 366 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #174.
Merriman Wealth Management first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. The position peaked at $860K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Merriman Wealth Management held 366 shares of Eli Lilly worth $283K as of Q4 2024.
- Merriman Wealth Management sold 604 Eli Lilly shares in Q4 2024, an estimated $500K.
- Eli Lilly made up 0.01% of Merriman Wealth Management's portfolio in Q4 2024, its #174 holding.
- Merriman Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
- Merriman Wealth Management's Eli Lilly position peaked at $860K in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Merriman Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.